MedTrace Logo

Borrelia Species in Cutaneous Lyme Borreliosis

NCT00576082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2022-06-30

No results posted yet for this study

Summary

The aim of this study is to identify the species of Borrelia involved in the dermatologic manifestations of Lyme borreliosis in France. Indeed, in Europe, as opposed to North America, many bacterial species are involved in Lyme borreliosis. Yet, very few is known about the prevalence and distribution of different bacteriological species that account for the disease in France. Thus, this a nation-wide study in which all French dermatologists are invited to participate. Every adult patient presenting with one of the cutaneous manifestation of Lyme borreliosis: erythema migrans, lymphocytoma or acrodermatitis chronica atrophicans can be included in the study. If the patient agrees participating, after information and written consent, a cutaneous biopsy will be performed in order to isolate Borrelia by means of culture and PCR. An estimated 400 biopsies should be performed within 2 years.

Conditions

  • Lyme Borreliosis

Interventions

OTHER

Cutaneous biopsy

Cutaneous biopsy in order to search Borrelia by means of culture and PCR in this tissue sample

Sponsors & Collaborators

  • Société de Dermatologie Française

    collaborator OTHER

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Dan LISPKER, MD · Hôpitaux Universitaires de Strasbourg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576082 on ClinicalTrials.gov